M&A momentum AleraCare merged with Pure Healthcare in May 2026, signaling ongoing consolidation in ambulatory infusion and home-based care. This creates cross-sell opportunities with Pure Infusion customers and a broader footprint to pursue enterprise contracts.

Ambulatory Infusion Access Specializes in ambulatory infusion centers, home infusion, and specialty pharmacies, presenting a clear entry point for partners serving physician offices and alternate care sites seeking integrated infusion solutions.

Private Equity Backing Past investments by Hildred Capital Partners and St. Cloud Capital highlight a history of capital support and growth intensity, suggesting readiness for scale-driven partnerships, managed services, or co-development initiatives.

Mid-market Footprint With 51-200 employees and revenue in the 10–25 million range, AleraCare sits in the mid-market segment, making it a suitable target for scalable partnerships, bundled service offerings, and regional expansion deals.

Tech and Ops Stack Utilizes industry tools and platforms (including McKesson, Rippling, Cloudflare, and site-focused technologies) that can be leveraged for integrations, data sharing, and streamlined contracting in pharmacy and infusion services.